查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2151783

放射性藥物CRO市場規模、佔有率和趨勢分析報告：按服務、放射性藥物類型、放射性核種類型、開發階段、應用、最終用戶、地區和細分市場預測（2026-2033年）

Radiopharmaceutical CRO Market Size, Share & Trends Analysis Report By Service, By Radiopharmaceutical Type, By Radionuclide, By Development Stage, By Application, By End User, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

放射性藥物 CRO 市場總結

全球放射性藥物 CRO 市場預計到 2025 年將達到 15 億美元，從 2026 年的 17 億美元成長到 2033 年的 39 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 12.7%。

北美是市場的主要驅動力，預計到 2025 年將佔據最大的銷售佔有率，達到 46.0%。市場成長的促進因素包括放射性配體療法產品線的擴張、靶向放射性藥物在腫瘤學領域的日益普及以及放射性藥物臨床試驗的日益複雜化。

對專業成像和劑量測定服務的需求日益成長，以及將藥物發現、臨床前研究、臨床研究、分析、法規事務和物流運營外包給專業合約研究組織（CRO）的趨勢不斷增強，預計將進一步推動放射性藥物CRO行業的成長。放射性同位素的半衰期短、對專用設施和設備的要求、輻射安全考量以及嚴格的監管要求，都進一步增加了對經驗豐富的服務供應商的需求。未來幾年，放射性藥物在腫瘤學、神經病學和循環系統的研發擴張預計將支持對專業CRO服務能力的需求。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：放射性藥物CRO市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技情勢
  • 定價模式分析
  • 關稅影響分析
  • 價值鏈分析
  • 市場分析工具

第4章：放射性藥物CRO市場：按服務類型分類的估算與趨勢分析

  • 放射性藥物CRO市場：按服務類型分類的趨勢分析
  • 放射性藥物CRO市場：按服務分類的估算與預測，2021-2033年
  • 臨床開發和臨床實驗管理服務
  • 臨床前研究服務
  • 成像和劑量測定服務
  • 放射化學服務
  • 分析測試實驗室服務
  • 藥品法規
  • 臨床用品/物流
  • 其他服務

第5章：放射性藥物CRO市場：依放射性藥物類型分類的估算與趨勢分析

  • 放射性藥物CRO市場：以放射性藥物類型分類的趨勢分析
  • 放射性藥物CRO市場估算與預測：按放射性藥物類型分類，2021-2033年
  • 診斷
  • 治療
  • 治療診斷學

第6章：放射性藥物CRO市場：依放射性核種分類的估算與趨勢分析

  • 放射性藥物CRO市場：以放射性核種類型分類的趨勢分析
  • 放射性藥物CRO市場估算與預測：依放射性核種類型分類，2021-2033年
  • 診斷放射性核種
  • 用於治療的放射性核種

第7章：放射性藥物CRO市場：依發展階段分類的估算與趨勢分析

  • 放射性藥物CRO市場：依發展階段分類的趨勢分析
  • 放射性藥物CRO市場估算與預測：依研發階段分類，2021-2033年
  • 藥物發現
  • 臨床前階段
  • 第0期/首次人體試驗
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第8章：放射性藥物CRO市場：按應用分類的估算與趨勢分析

  • 放射性藥物CRO市場：按應用領域分類的趨勢分析
  • 放射性藥物CRO市場：按應用領域分類的估算與預測，2021-2033年
  • 腫瘤學
  • 神經病學
  • 循環系統
  • 感染疾病
  • 其他用途

第9章：放射性藥物CRO市場：依最終用戶分類的估算與趨勢分析

  • 放射性藥物CRO市場：依最終用戶分類的趨勢分析
  • 放射性藥物CRO市場：按最終用戶分類的估算和預測，2021-2033年
  • 製藥和生物技術公司
  • 放射性藥物生產商
  • 學術研究機構
  • 其他

第10章：放射性藥物CRO市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特
    • 阿曼
    • 卡達

第11章 競爭格局

  • 主要公司分類
    • Market Leaders
    • Emerging Players
  • 2025年市佔率及估值分析（熱圖分析）
  • 公司簡介
    • IQVIA Holdings Inc.
    • ICON plc
    • Charles River Laboratories
    • Thermo Fisher Scientific（PPD）
    • Labcorp Holdings Inc.
    • WuXi AppTec
    • Medpace Holdings, Inc.
    • Perceptive
    • TRACER
    • Pharmaron
    • ABX-CRO
    • PSI
    • Minerva Imaging
Product Code: GVR-4-68041-030-1

Radiopharmaceutical CRO Market Summary

The global radiopharmaceutical CRO market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 3.9 billion by 2033, at a CAGR of 12.7% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 46.0% in 2025. The market growth is driven by the expanding radioligand therapy pipeline, increasing adoption of targeted radiopharmaceuticals in oncology, and rising complexity of radiopharmaceutical clinical trials.

The growing demand for specialized imaging and dosimetry services, and increasing outsourcing of discovery, preclinical, clinical, analytical, regulatory, and logistics activities to specialized CROs are expected to further fuel the growth of the radiopharmaceutical CRO industry. The short half-lives of radioisotopes, specialized site and facility requirements, radiation safety considerations, and stringent regulatory requirements further increase the need for experienced service providers. The expansion of radiopharmaceutical development across oncology, neurology, and cardiology is expected to support demand for specialized CRO capabilities over the coming years.

Global Radiopharmaceutical CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global radiopharmaceutical CRO market report based on service, radiopharmaceutical type, radionuclide, development stage, application, end user, and region:

  • Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Clinical Development & Trial Management Services
    • Clinical Development & Protocol Design
    • Clinical Trial Management
    • Site Management
    • Patient Recruitment & Investigator Management
    • Data Management & Biostatistics
    • Other Clinical Services
  • Preclinical Research Services
    • Preclinical Pharmacology & Efficacy
    • ADME & PK/PD
    • Toxicology & Safety Assessment
    • Others
  • Imaging & Dosimetry Services
    • Nuclear Imaging Services
    • Image Analysis & Quantification
    • Biodistribution & Functional Imaging
    • Radiation Dosimetry
    • Other Imaging & Dosimetry Services
  • Radiochemistry Services
  • Analytical Laboratory Services
  • Regulatory Affairs
  • Clinical Supply & Logistics
  • Other Services
  • Radiopharmaceutical Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Diagnostic
  • Therapeutic
  • Theranostic
  • Radionuclide Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Diagnostic Radionuclides
  • Therapeutic Radionuclides
  • Development Stage Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Drug Discovery
  • Preclinical
  • Phase 0 / First-in-Human
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Other Applications
  • End User Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Pharma & Biotech Companies
  • Radiopharmaceutical Companies
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Radiopharmaceutical Type
    • 1.2.3. Radionuclide
    • 1.2.4. Development Stage
    • 1.2.5. Application
    • 1.2.6. End User
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Radiopharmaceutical CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. Radiopharmaceutical CRO Market: Service Estimates & Trend Analysis

  • 4.1. Radiopharmaceutical CRO Market, By Service: Segment Dashboard
  • 4.2. Radiopharmaceutical CRO Market, By Service: Movement Analysis
  • 4.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Service, 2021 - 2033
  • 4.4. Clinical Development & Trial Management Services
    • 4.4.1. Clinical Development & Trial Management Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.1.1. Clinical Development & Protocol Design
        • 4.4.1.1.1. Clinical Development & Protocol Design Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.1.2. Clinical Trial Management
        • 4.4.1.2.1. Clinical Trial Management Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.1.3. Site Management
        • 4.4.1.3.1. Site Management Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.1.4. Patient Recruitment & Investigator Management
        • 4.4.1.4.1. Patient Recruitment & Investigator Management Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.1.5. Data Management & Biostatistics
        • 4.4.1.5.1. Data Management & Biostatistics Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.4.1.6. Other Clinical Services
        • 4.4.1.6.1. Other Clinical Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.5. Preclinical Research Services
    • 4.5.1. Preclinical Research Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.5.1.1. Preclinical Pharmacology & Efficacy
        • 4.5.1.1.1. Preclinical Pharmacology & Efficacy Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.5.1.2. ADME & PK/PD
        • 4.5.1.2.1. ADME & PK/PD Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.5.1.3. Toxicology & Safety Assessment
        • 4.5.1.3.1. Toxicology & Safety Assessment Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.5.1.4. Others
        • 4.5.1.4.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.6. Imaging & Dosimetry Services
    • 4.6.1. Imaging & Dosimetry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.6.1.1. Nuclear Imaging Services
        • 4.6.1.1.1. Nuclear Imaging Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.6.1.2. Image Analysis & Quantification
        • 4.6.1.2.1. Image Analysis & Quantification Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.6.1.3. Biodistribution & Functional Imaging
        • 4.6.1.3.1. Biodistribution & Functional Imaging Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.6.1.4. Radiation Dosimetry
        • 4.6.1.4.1. Radiation Dosimetry Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
      • 4.6.1.5. Other Imaging & Dosimetry Services
        • 4.6.1.5.1. Other Imaging & Dosimetry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.7. Radiochemistry Services
    • 4.7.1. Radiochemistry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.8. Analytical Laboratory Services
    • 4.8.1. Analytical Laboratory Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.9. Regulatory Affairs
    • 4.9.1. Regulatory Affairs Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.10. Clinical Supply & Logistics
    • 4.10.1. Clinical Supply & Logistics Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.11. Other Services
    • 4.11.1. Other Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 5. Radiopharmaceutical CRO Market: Radiopharmaceutical Type Estimates & Trend Analysis

  • 5.1. Radiopharmaceutical CRO Market, By Radiopharmaceutical Type: Segment Dashboard
  • 5.2. Radiopharmaceutical CRO Market, By Radiopharmaceutical Type: Movement Analysis
  • 5.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Radiopharmaceutical Type, 2021 - 2033
  • 5.4. Diagnostic
    • 5.4.1. Diagnostic Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 5.5. Therapeutic
    • 5.5.1. Therapeutic Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 5.6. Theranostic
    • 5.6.1. Theranostic Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 6. Radiopharmaceutical CRO Market: Radionuclide Estimates & Trend Analysis

  • 6.1. Radiopharmaceutical CRO Market, By Radionuclide: Segment Dashboard
  • 6.2. Radiopharmaceutical CRO Market, By Radionuclide: Movement Analysis
  • 6.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Radionuclide, 2021 - 2033
  • 6.4. Diagnostic Radionuclides
    • 6.4.1. Diagnostic Radionuclides Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 6.5. Therapeutic Radionuclides
    • 6.5.1. Therapeutic Radionuclides Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 7. Radiopharmaceutical CRO Market: Development Stage Estimates & Trend Analysis

  • 7.1. Radiopharmaceutical CRO Market, By Development Stage: Segment Dashboard
  • 7.2. Radiopharmaceutical CRO Market, By Development Stage: Movement Analysis
  • 7.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Development Stage, 2021 - 2033
  • 7.4. Drug Discovery
    • 7.4.1. Drug Discovery Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 7.5. Preclinical
    • 7.5.1. Preclinical Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 7.6. Phase 0 / First-in-Human
    • 7.6.1. Phase 0 / First-in-Human Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 7.7. Phase I
    • 7.7.1. Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 7.8. Phase II
    • 7.8.1. Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 7.9. Phase III
    • 7.9.1. Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 7.10. Phase IV
    • 7.10.1. Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 8. Radiopharmaceutical CRO Market: Application Estimates & Trend Analysis

  • 8.1. Radiopharmaceutical CRO Market, By Application: Segment Dashboard
  • 8.2. Radiopharmaceutical CRO Market, By Application: Movement Analysis
  • 8.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Application, 2021 - 2033
  • 8.4. Oncology
    • 8.4.1. Oncology Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 8.5. Neurology
    • 8.5.1. Neurology Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 8.6. Cardiology
    • 8.6.1. Cardiology Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 8.7. Infectious Diseases
    • 8.7.1. Infectious Diseases Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 8.8. Other Applications
    • 8.8.1. Other Applications Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 9. Radiopharmaceutical CRO Market: End User Estimates & Trend Analysis

  • 9.1. Radiopharmaceutical CRO Market, By End User: Segment Dashboard
  • 9.2. Radiopharmaceutical CRO Market, By End User: Movement Analysis
  • 9.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By End User, 2021 - 2033
  • 9.4. Pharma & Biotech Companies
    • 9.4.1. Pharma & Biotech Companies Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 9.5. Radiopharmaceutical Companies
    • 9.5.1. Radiopharmaceutical Companies Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 9.6. Academic & Research Institutes
    • 9.6.1. Academic & Research Institutes Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 9.7. Others
    • 9.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 10. Radiopharmaceutical CRO Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Dashboard
  • 10.2. Regional Market Share Analysis, 2025 & 2033
  • 10.3. North America
    • 10.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.3.2. U.S
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Framework
      • 10.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Framework
      • 10.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.3.4. Mexico
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Regulatory Framework
      • 10.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 10.4. Europe
    • 10.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Regulatory Framework
      • 10.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Regulatory Framework
      • 10.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Regulatory Framework
      • 10.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Regulatory Framework
      • 10.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Regulatory Framework
      • 10.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Regulatory Framework
      • 10.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Regulatory Framework
      • 10.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Regulatory Framework
      • 10.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.5.2. Japan
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Regulatory Framework
      • 10.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.5.3. China
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Regulatory Framework
      • 10.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.5.4. India
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Regulatory Framework
      • 10.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.5.5. Thailand
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Competitive Scenario
      • 10.5.5.3. Regulatory Framework
      • 10.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.5.6. South Korea
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Competitive Scenario
      • 10.5.6.3. Regulatory Framework
      • 10.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.5.7. Australia
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Competitive Scenario
      • 10.5.7.3. Regulatory Framework
      • 10.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 10.6. Latin America
    • 10.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Regulatory Framework
      • 10.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.6.3. Argentina
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Regulatory Framework
      • 10.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 10.7. MEA
    • 10.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Regulatory Framework
      • 10.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Competitive Scenario
      • 10.7.3.3. Regulatory Framework
      • 10.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Regulatory Framework
      • 10.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Regulatory Framework
      • 10.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.7.6. Oman
      • 10.7.6.1. Key Country Dynamics
      • 10.7.6.2. Competitive Scenario
      • 10.7.6.3. Regulatory Framework
      • 10.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 10.7.7. Qatar
      • 10.7.7.1. Key Country Dynamics
      • 10.7.7.2. Competitive Scenario
      • 10.7.7.3. Regulatory Framework
      • 10.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 11. Competitive Landscape

  • 11.1. Key Participant Categorization
    • 11.1.1. Market Leaders
    • 11.1.2. Emerging Players
  • 11.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 11.3. Company Profiles
    • 11.3.1. IQVIA Holdings Inc.
      • 11.3.1.1. Company Overview
      • 11.3.1.2. Financial Performance
      • 11.3.1.3. Service Benchmarking
      • 11.3.1.4. Strategic Initiatives
    • 11.3.2. ICON plc
      • 11.3.2.1. Company Overview
      • 11.3.2.2. Financial Performance
      • 11.3.2.3. Service Benchmarking
      • 11.3.2.4. Strategic Initiatives
    • 11.3.3. Charles River Laboratories
      • 11.3.3.1. Company Overview
      • 11.3.3.2. Financial Performance
      • 11.3.3.3. Service Benchmarking
      • 11.3.3.4. Strategic Initiatives
    • 11.3.4. Thermo Fisher Scientific (PPD)
      • 11.3.4.1. Company Overview
      • 11.3.4.2. Financial Performance
      • 11.3.4.3. Service Benchmarking
      • 11.3.4.4. Strategic Initiatives
    • 11.3.5. Labcorp Holdings Inc.
      • 11.3.5.1. Company Overview
      • 11.3.5.2. Financial Performance
      • 11.3.5.3. Service Benchmarking
      • 11.3.5.4. Strategic Initiatives
    • 11.3.6. WuXi AppTec
      • 11.3.6.1. Company Overview
      • 11.3.6.2. Financial Performance
      • 11.3.6.3. Service Benchmarking
      • 11.3.6.4. Strategic Initiatives
    • 11.3.7. Medpace Holdings, Inc.
      • 11.3.7.1. Company Overview
      • 11.3.7.2. Financial Performance
      • 11.3.7.3. Service Benchmarking
      • 11.3.7.4. Strategic Initiatives
    • 11.3.8. Perceptive
      • 11.3.8.1. Company Overview
      • 11.3.8.2. Financial Performance
      • 11.3.8.3. Service Benchmarking
      • 11.3.8.4. Strategic Initiatives
    • 11.3.9. TRACER
      • 11.3.9.1. Company Overview
      • 11.3.9.2. Financial Performance
      • 11.3.9.3. Service Benchmarking
      • 11.3.9.4. Strategic Initiatives
    • 11.3.10. Pharmaron
      • 11.3.10.1. Company Overview
      • 11.3.10.2. Financial Performance
      • 11.3.10.3. Service Benchmarking
      • 11.3.10.4. Strategic Initiatives
    • 11.3.11. ABX-CRO
      • 11.3.11.1. Company Overview
      • 11.3.11.2. Financial Performance
      • 11.3.11.3. Service Benchmarking
      • 11.3.11.4. Strategic Initiatives
    • 11.3.12. PSI
      • 11.3.12.1. Company Overview
      • 11.3.12.2. Financial Performance
      • 11.3.12.3. Service Benchmarking
      • 11.3.12.4. Strategic Initiatives
    • 11.3.13. Minerva Imaging
      • 11.3.13.1. Company Overview
      • 11.3.13.2. Financial Performance
      • 11.3.13.3. Service Benchmarking
      • 11.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Radiopharmaceutical CRO Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million/Billion)
  • Table 4 Global Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 5 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 6 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 7 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 8 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 9 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 10 North America Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 11 North America Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 12 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 13 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 14 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 15 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 16 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 17 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 18 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 19 U.S.Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 20 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 21 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 22 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 23 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 24 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 25 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 26 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 27 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 28 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 29 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 30 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 31 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 32 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 33 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 34 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 35 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 36 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 37 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 38 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 39 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 40 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 41 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 42 UK Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 43 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 44 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 45 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 46 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 47 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 48 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 49 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 50 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 51 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 52 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 53 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 54 France Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 55 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 56 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 57 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 58 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 59 France Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 60 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 61 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 62 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 63 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 64 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 65 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 66 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 67 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 68 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 69 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 70 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 71 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 72 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 73 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 74 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 75 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 76 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 77 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 78 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 79 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 80 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 81 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 82 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 83 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 84 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 85 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 86 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 87 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 88 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 89 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 90 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 91 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 92 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 93 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 94 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 95 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 96 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 97 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 98 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 99 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 100 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 101 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 102 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 103 China Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 104 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 105 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 106 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 107 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 108 China Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 109 India Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 110 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 111 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 112 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 113 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 114 India Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 115 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 116 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 117 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 118 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 119 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 120 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 121 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 122 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 123 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 124 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 125 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 126 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 127 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 128 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 129 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 130 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 131 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 132 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 133 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 134 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 135 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 136 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 137 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 138 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 139 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 140 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 141 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 142 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 143 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 144 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 145 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 146 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 147 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 148 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 149 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 150 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 151 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 152 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 153 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 154 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 155 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 156 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 157 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 158 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 159 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 160 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 161 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 162 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 163 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 164 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 165 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 166 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 167 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 168 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 169 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 170 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 171 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 172 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 173 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 174 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 175 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 176 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 177 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 178 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 179 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 180 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 181 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 182 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 183 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 184 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 185 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 186 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 187 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 188 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
  • Table 189 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
  • Table 190 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
  • Table 191 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
  • Table 192 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
  • Table 193 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
  • Table 194 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value-Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Radiopharmaceutical CRO Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Radiopharmaceutical CRO Market: Service outlook and key takeaways
  • Fig. 20 Radiopharmaceutical CRO Market: Service movement analysis
  • Fig. 21 Clinical Development & Trial Management Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 22 Clinical Development & Protocol Design Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 23 Clinical Trial Management Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 24 Site Management Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 25 Patient Recruitment & Investigator Management Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 26 Data Management & Biostatistics Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 27 Other Clinical Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 28 Preclinical Pharmacology & Efficacy Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 29 ADME & PK/PD Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 30 Toxicology & Safety Assessment Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 31 Others Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 32 Imaging & Dosimetry Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 33 Nuclear Imaging Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 34 Image Analysis & Quantification Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 35 Biodistribution & Functional Imaging Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 36 Radiation Dosimetry Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 37 Other Imaging & Dosimetry Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 38 Radiochemistry Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 39 Analytical Laboratory Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 40 Regulatory Affairs Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 41 Clinical Supply & Logistics Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 42 Other Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 43 Radiopharmaceutical CRO Market: Radiopharmaceutical Type outlook and key takeaways
  • Fig. 44 Radiopharmaceutical CRO Market: Radiopharmaceutical Type movement analysis
  • Fig. 45 Diagnostic Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 46 Therapeutic Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 47 Theranostic Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 48 Radiopharmaceutical CRO Market: Radionuclide outlook and key takeaways
  • Fig. 49 Radiopharmaceutical CRO Market: Radionuclide movement analysis
  • Fig. 50 Diagnostic Radionuclides Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 51 Therapeutic Radionuclides Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 52 Radiopharmaceutical CRO Market: Development Stage outlook and key takeaways
  • Fig. 53 Radiopharmaceutical CRO Market: Development Stage movement analysis
  • Fig. 54 Drug Discovery Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 55 Preclinical Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 56 Phase 0 / First-in-Human Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 57 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 58 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 59 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 60 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 61 Radiopharmaceutical CRO Market: Application outlook and key takeaways
  • Fig. 62 Radiopharmaceutical CRO Market: Application movement analysis
  • Fig. 63 Oncology Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 64 Neurology Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 65 Cardiology Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 66 Infectious Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 67 Other Applications Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 68 Radiopharmaceutical CRO Market: End User outlook and key takeaways
  • Fig. 69 Radiopharmaceutical CRO Market: End User movement analysis
  • Fig. 70 Pharma & Biotech Companies Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 71 Radiopharmaceutical Companies Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 72 Academic & Research Institutes Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 73 Others Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
  • Fig. 74 Regional Marketplace: Key Takeaways
  • Fig. 75 North America Radiopharmaceutical CRO Market estimates and forecasts, 202 - 2033 (USD Million/Billion)
  • Fig. 76 Key country dynamics
  • Fig. 77 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 78 Key country dynamics
  • Fig. 79 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 80 Key country dynamics
  • Fig. 81 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 82 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 UK Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 85 Key country dynamics
  • Fig. 86 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 87 Key country dynamics
  • Fig. 88 France Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 93 Key country dynamics
  • Fig. 94 Denmark Radiopharmaceutical CRO Market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 95 Key country dynamics
  • Fig. 96 Sweden Radiopharmaceutical CRO Market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 97 Key country dynamics
  • Fig. 98 Norway Radiopharmaceutical CRO Market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 99 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 100 Key country dynamics
  • Fig. 101 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 102 Key country dynamics
  • Fig. 103 China Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 104 Key country dynamics
  • Fig. 105 India Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 106 Key country dynamics
  • Fig. 107 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 108 Key country dynamics
  • Fig. 109 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 110 Key country dynamics
  • Fig. 111 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 112 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 113 Key country dynamics
  • Fig. 114 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 115 Key country dynamics
  • Fig. 116 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 117 MEA Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 118 Key country dynamics
  • Fig. 119 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 120 Fig. Key country dynamics
  • Fig. 121 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 122 Key country dynamics
  • Fig. 123 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 124 Key country dynamics
  • Fig. 125 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 126 Key country dynamics
  • Fig. 127 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 128 Key country dynamics
  • Fig. 129 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)